Mirus Bio LLC, based in Madison, WI, is a leading provider of nucleic acid delivery systems, specializing in transfection solutions for a wide range of applications including cell and gene therapy, protein production, and viral vector manufacturing. Since its founding in 1995, Mirus Bio has been at the forefront of transforming the science of transfection through intentional design, offering innovative products such as the Revit AAV Enhancer and Transit VirusGEN Transfection Reagent.
With a focus on quality and process excellence, Mirus Bio recently received ISO 13485:2016 certification, underscoring the company's commitment to delivering high-quality products and support to its global network of distributors. Through a dedication to groundbreaking discoveries and advanced therapies, Mirus Bio continues to drive innovation in nucleic acid delivery systems for researchers and biopharmaceutical companies worldwide.
Generated from the website